Hemodynamic contribution of stem cell scaffolding in acute injured myocardium

Tissue Engineering - Part A

Volumn 18, Issue 15-16, 2012, Pages 1652-1663

  Qian, Ling ^a   Shim, Winston ^a,b   Gu, Yacui ^a   Shirhan, Mohamed ^a   Lim, Kee Pah ^a   Tan, Lay Poh ^c   Lim, Chong Hee ^a   Sin, Yoong Kong ^a   Wong, Philip ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; HYDROGELS; STEM CELLS; TISSUE;

CARDIAC CELL; CELL RETENTION; CELL SCAFFOLDING; DIASTOLIC FUNCTION; EJECTION FRACTION; END-DIASTOLIC; END-SYSTOLIC; HIGH DOSE; LEFT VENTRICULAR; LOW DOSE; POWER FIELDS; PRE LOADS; RAT MODEL; SCAFFOLDING MATERIALS; SERUM-FREE MEDIUM; STEM CELL TRANSPLANTATION; TARGETED DELIVERY; TISSUE-ENGINEERED SCAFFOLDS; VENTRICULAR WALLS; WALL MECHANICS;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL; APOPTOSIS; ARTICLE; CELL COUNT; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ECHOGRAPHY; HEART CONTRACTION; HEART FUNCTION TEST; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE; HEMODYNAMICS; HUMAN; MALE; MATERIALS TESTING; MECHANICS; NICK END LABELING; PATHOPHYSIOLOGY; RAT; STEM CELL; STEM CELL TRANSPLANTATION; TRANSPLANTATION; WISTAR RAT;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL COUNT; HEART FUNCTION TESTS; HEART VENTRICLES; HEMODYNAMICS; HUMANS; IN SITU NICK-END LABELING; MALE; MATERIALS TESTING; MECHANICAL PHENOMENA; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE SCAFFOLDS;

EID: 84865271952     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0591     Document Type: Article

References (48)

1. Lloyd-Jones, D., Adams, R.J., Brown, T.M., et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, 948, 2010.
2. Williams, A.R., and Hare, J.M. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109, 923, 2011.
3. Assmus, B., Schachinger, V., Teupe, C., et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106, 3009, 2002.
4. Fuchs, S., Satler, L.F., Kornowski, R., et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 41, 1721, 2003.
5. Perin, E.C., Dohmann, H.F., Borojevic, R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107, 2294, 2003.
6. Stamm, C., Westphal, B., Kleine, H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45, 2003.
7. Tse, H.F., Kwong, Y.L., Chan, J.K., Lo, G., Ho, C.L., and Lau, C.P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361, 47, 2003.
8. Charwat, S., Lang, I., Dettke, M., et al. Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost 103, 564, 2010.
9. Wollert, K.C., Messinger, D., Arseniev, L., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141, 2004.
10. Hirsch, A., Nijveldt, R., van der Vleuten, P.A., et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 32, 1736, 2010.
11. Kochupura, P.V., Azeloglu, E.U., Kelly, D.J., et al. Tissueengineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 112 9 Suppl, I144, 2005.
12. Gaballa, M.A., Sunkomat JNE, Thai, H., Morkin, E., Ewy, G., and Goldman, S. Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J Heart Lung Transplant 25, 946, 2006.
13. Traverse, J.H. Using biomaterials to improve the efficacy of cell therapy following acute myocardial infarction. J Cardiovasc Transl Res 5, 67, 2011.
14. Kuraitis, D., Giordano, C., Ruel, M., Musaro, A., and Suuronen, E.J. Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. Biomaterials 33, 428, 2012.
15. Callegari, A., Bollini, S., Iop, L., et al. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 28, 5449, 2007.
16. Wall, S.T., Walker, J.C., Healy, K.E., Ratcliffe, M.B., and Guccione, J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 114, 2627, 2006.
17. Fukushima, S., Varela-Carver, A., Coppen, S.R., et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115, 2254, 2007.
18. Shim WSN, Tan, G., Gu, Y., et al. Dose-dependent systolic contribution of differentiated stem cells in post-infarct ventricular function. J Heart Lung Transplant 29, 1415, 2010.
19. Segers, V.F.M., and Lee, R.T. Biomaterials to enhance stem cell function in the heart. Circ Res 109, 910, 2011.
20. Piao, H., Kwon, J.S., Piao, S., et al. Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials 28, 641, 2007.
21. Zimmermann, W.H., Didie, M., Doker, S., et al. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 71, 419, 2006.
22. Chachques, J.C., Trainini, J.C., Lago, N., Cortes-Morichetti, M., Schussler, O., and Carpentier, A. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg 85, 901, 2008.
23. Mann, D.L., Kubo, S.H., Sabbah, H.N., et al. Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial. J Thorac Cardiovasc Surg 143, 1036, 2012.
24. Kocher, A.A., Schuster, M.D., Szabolcs, M.J., et al. Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7, 430, 2001.
25. Agbulut, O., Vandervelde, S., Al Attar, N., et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133 + progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 44, 458, 2004.
26. Yoon, Y.S., Wecker, A., Heyd, L., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115, 326, 2005.
27. Tan, G., Chua, T., Wong, P., et al. Directed Differentiation of Adult Human Bone Marrow Mesenchymal Stem cell Towards Cardiomyocytes. Ann Acad Med Singapore 33, S182, 2004.
28. Shim, W., Tan, G., Sim, E., and Wong, P. Collagen V matrix supports proliferation and differentiation of cardiomyocytelike cells from adult human bone marrow. Cytotherpy 7 Suppl 1, 194, 2005.
29. Shim, W., Tan, G., and Wong, P. Large-Scale Expansion of Cardiomyocyte-like Cells for Cell Therapy. Circulation 112 Suppl II, II-14, 2005.
30. Shim, W.S., Jiang, S., Wong, P., et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 324, 481, 2004.
31. Quinones, M.A., Waggoner, A.D., Reduto, L.A., et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 64, 744, 1981.
32. Pacher, P., Mabley, J.G., Liaudet, L., et al. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol 287, H2132, 2004.
33. Shim, W.S., Li, W., Zhang, L., et al. Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model. J Biomed Sci 13, 579, 2006.
34. Peirce, S.M., Price, R.J., and Skalak, T.C. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am J Physiol Heart Circ Physiol 286, H918, 2004.
35. Hirata, Y., Sata, M., Motomura, N., et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun 327, 609, 2005.
36. Mezger, T. The Rheology Handbook: For Users of Rotational and Oscillatory Rheometers. Hannover: Vincentz Verlag, 2002.
37. Kouris, N.A., Squirrell, J.M., Jung, J.P., et al. A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart. Regenerative Med 6, 569, 2011.
38. Ryu, J.H., Kim, I.K., Cho, S.W., et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26, 319, 2005.
39. Pozzobon, M., Bollini, S., Iop, L., et al. Human bone marrowderived CD133 (+) cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis. Cell Transplant 19, 1247, 2010.
40. Starling, R.C., Jessup, M., Oh, J.K., et al. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial. Ann Thorac Surg 84, 1236, 2007.
41. Berry, M.F., Engler, A.J., Woo, Y.J., et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290, H2196, 2006.
42. Hamdi, H., Planat-Benard Vr, Bel, A., et al. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc Res 91, 483, 2011.
43. Goktepe, S., Abilez, O.J., Parker, K.K., and Kuhl, E. A multiscale model for eccentric and concentric cardiac growth through sarcomerogenesis. J Theor Biol 265, 433, 2010.
44. Zhang, Z., Tendulkar, A., Sun, K., et al. Comparison of the Young-Laplace law and finite element based calculation of ventricular wall stress: implications for postinfarct and surgical ventricular remodeling. Ann Thorac Surg 91, 150, 2011.
45. Coppola, B.A., and Omens, J.H. Role of tissue structure on ventricular wall mechanics. Mol Cell Biomech 5, 183, 2008.
46. Cleutjens, J.P.,Blankesteijn,W.M.,Daemen,M.J., andSmits, J.F. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 44, 232, 1999.
47. Simpson, D., Liu, H., Fan, T.H., Nerem, R., and Dudley, S.C., Jr. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25, 2350, 2007.
48. Shi, C., Li, Q., Zhao, Y., et al. Stem-cell-capturing collagen scaffold promotes cardiac tissue regeneration. Biomaterials 32, 2508, 2011.